Literature DB >> 30936783

Modulated volumetric arc therapy for total marrow irradiation: A feasibility study in the oncology hospital of CMN SXXI from a medical physics approach.

Jesus Gerardo Gutiérrez1,2, Armando Felix3, Alberto López1,2, Teodoro Rivera1.   

Abstract

AIM: The objective of this study is to explore the use of volumetric arc therapy (VMAT) to perform total marrow irradiation (TMI) and compare its results to the standard TBI technique in the Mexican public health system.
BACKGROUND: The standard total body irradiation (TBI) technique is used with chemotherapy as a method of a pre-transplant conditioning of the bone marrow. In this technique, the whole body of the patient is considered to be PTV and irradiated generating toxicities and raising concerns about possible development of radio-induced tumors.
MATERIALS AND METHODS: Through the use of simulation tomography of 12 patients previously treated with TBI, twelve different treatment plans were created with the proposed TMI technique and compared with the conventional protocol, the treatment plans were evaluated with a dose volume histogram analysis and quality assurance was evaluated with a portal dosimetry system using the gamma index criteria 3%/3 mm.
RESULTS: Experimental results show an increasing dose to 99% of PTV of up to 41.1% by using TMI with the VMAT technique. The mean average dose to PTV was increased up to 19.3%. The use of the new TMI technique caused an improvement in the mean average dose to 99% of the PTV as well the homogeneity of the dose distribution prescribed at the PTV while leading to a better reproducibility of the treatment. The Qa of all the plans met the criterion of gamma index 3 mm-3%.
CONCLUSION: The results analysis shows that the proposed TMI technique is feasible and applicable in the Mexican public health system.

Entities:  

Keywords:  Total body irradiation; Total marrow irradiation; Volumetric arc therapy

Year:  2019        PMID: 30936783      PMCID: PMC6426710          DOI: 10.1016/j.rpor.2019.03.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  13 in total

1.  Total body irradiation before allogeneic bone marrow transplantation: is more dose better?

Authors:  S Bieri; C Helg; B Chapuis; R Miralbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

2.  Feasibility study of helical tomotherapy for total body or total marrow irradiation.

Authors:  Susanta K Hui; Jeff Kapatoes; Jack Fowler; Douglas Henderson; Gustavo Olivera; Rafael R Manon; Bruce Gerbi; T R Mackie; James S Welsh
Journal:  Med Phys       Date:  2005-10       Impact factor: 4.071

3.  Image-guided total marrow and total lymphatic irradiation using helical tomotherapy.

Authors:  Timothy E Schultheiss; Jeffrey Wong; An Liu; Gustavo Olivera; George Somlo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-15       Impact factor: 7.038

4.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

5.  Total marrow irradiation with RapidArc volumetric arc therapy.

Authors:  Bulent Aydogan; Mete Yeginer; Gulbin O Kavak; John Fan; James A Radosevich; Kim Gwe-Ya
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-02-23       Impact factor: 7.038

6.  Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.

Authors:  D Blaise; D Maraninchi; E Archimbaud; J Reiffers; A Devergie; J P Jouet; N Milpied; M Attal; M Michallet; N Ifrah
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

7.  Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

Authors:  O Ringdén; M Remberger; T Ruutu; J Nikoskelainen; L Volin; L Vindeløv; T Parkkali; S Lenhoff; B Sallerfors; L Mellander; P Ljungman; N Jacobsen
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

8.  Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation.

Authors:  Jeffrey Y C Wong; An Liu; Timothy Schultheiss; Leslie Popplewell; Anthony Stein; Joseph Rosenthal; Mark Essensten; Stephen Forman; George Somlo
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

9.  Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.

Authors:  G Socié; R A Clift; D Blaise; A Devergie; O Ringden; P J Martin; M Remberger; H J Deeg; T Ruutu; M Michallet; K M Sullivan; S Chevret
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

10.  Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.

Authors:  W Hasegawa; G R Pond; J T Rifkind; H A Messner; A Lau; A S Daly; T L Kiss; N Kotchetkova; A Galal; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2005-01       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.